J.&J.’s vaccine should carry warning of potential risk for rare blood clots, the E.U.’s regulator says, but believes benefits outweigh risks.

By BY MATINA STEVIS-GRIDNEFF from NYT World https://nyti.ms/3dyE6AY New York Times